Pulmonx (LUNG)
(Delayed Data from NSDQ)
$7.51 USD
+0.64 (9.32%)
Updated Aug 23, 2024 04:00 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for Pulmonx Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -60.84 | -58.92 | -48.66 | -32.23 | -20.70 |
Depreciation/Amortization & Depletion | 0.57 | 1.37 | 1.03 | 1.42 | 0.33 |
Net Change from Assets/Liabilities | -2.56 | -7.01 | -7.85 | -4.79 | -2.40 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 25.22 | 19.49 | 14.09 | 4.97 | 2.01 |
Net Cash From Operating Activities | -37.61 | -45.08 | -41.39 | -30.63 | -20.77 |
Property & Equipment | -0.81 | -1.32 | -3.67 | -0.91 | -0.72 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -1.20 | -2.91 | -42.58 | 13.61 | -13.51 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -2.01 | -4.23 | -46.26 | 12.69 | -14.23 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.49 | 2.56 | 4.50 | 206.34 | 40.19 |
Issuance (Repayment) of Debt | 19.91 | -0.09 | 0.00 | 32.99 | 6.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -0.05 | -0.04 | -4.50 | -0.57 |
Net Cash from Financing Activities | 21.40 | 2.42 | 4.46 | 234.83 | 45.62 |
Effect of Exchange Rate Changes | 0.03 | 0.15 | 0.11 | 0.13 | 0.02 |
Net Change In Cash & Equivalents | -18.18 | -46.74 | -83.08 | 217.03 | 10.64 |
Cash at Beginning of Period | 101.97 | 148.71 | 231.79 | 14.77 | 4.12 |
Cash at End of Period | 83.78 | 101.97 | 148.71 | 231.79 | 14.77 |
Diluted Net EPS | -1.60 | -1.59 | -1.35 | -3.16 | -11.66 |
Fiscal Year End for Pulmonx Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -29.08 | -13.75 | -60.84 | -46.96 | -32.06 |
Depreciation/Amortization & Depletion | -0.02 | 0.05 | 0.57 | 0.60 | 0.43 |
Net Change from Assets/Liabilities | -3.32 | -4.63 | -2.56 | -2.14 | -1.12 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 14.85 | 6.54 | 25.22 | 19.33 | 12.20 |
Net Cash From Operating Activities | -17.57 | -11.80 | -37.61 | -29.16 | -20.54 |
Property & Equipment | -0.92 | -0.45 | -0.81 | -0.61 | -0.12 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -2.42 | -2.06 | -1.20 | 1.36 | -0.12 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -3.34 | -2.51 | -2.01 | 0.75 | -0.24 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.89 | 0.86 | 1.49 | 1.43 | 0.86 |
Issuance (Repayment) of Debt | -0.05 | 0.00 | 19.91 | 19.95 | 19.95 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.84 | 0.86 | 21.40 | 21.38 | 20.81 |
Effect of Exchange Rate Changes | 0.00 | 0.05 | 0.03 | 0.24 | 0.04 |
Net Change In Cash & Equivalents | -20.06 | -13.39 | -18.18 | -6.79 | 0.08 |
Cash at Beginning of Period | 83.78 | 83.78 | 101.97 | 101.97 | 101.97 |
Cash at End of Period | 63.72 | 70.39 | 83.78 | 95.18 | 102.05 |
Diluted Net EPS | -0.39 | -0.36 | -0.36 | -0.39 | -0.43 |